Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novavax Stock Was Down in the Dumps This Week


Shares of Novavax (NASDAQ: NVAX) slipped as much as 23% this week, according to data from S&P Global Market Intelligence. The COVID-19 vaccine maker missed earnings and revenue estimates for the fourth quarter, causing investors to sell off the stock once again. The share price is now down 90% over the past year after soaring as much as 2,000% during the beginning of its COVID vaccine rollout.

NVAX Chart

NVAX data by YCharts.

Continue reading


Source Fool.com

Like: 0
Share

Comments